BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.

Datwyler is a leading specialist for system-critical elastomer components and a key player in the global healthcare market. Our state-of-the-art solutions for drug packaging and medical devices build over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services, including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. With our global production footprint, we make an important contribution to our customers' reliable supply chain. Partnering with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to improve patients’ lives.

SGS Vitrology, part of the SGS global network, provides trusted virology and biosafety testing services to support vaccine development, manufacturing, and regulatory compliance. With deep expertise in viral clearance studies, cell-based assays, and microbiological testing, SGS partners with pharmaceutical and biotech organisations to ensure the safety, efficacy, and quality of biologics and vaccines.

At a time of rapid vaccine innovation and expanding manufacturing capacity in India, SGS Vitrology offers robust, globally harmonised solutions aligned with international regulatory standards. Our laboratories combine scientific excellence with advanced technologies to accelerate development timelines while maintaining strict quality assurance.

For organisations attending the World Vaccines Forum in Pune, SGS Vitrology is a reliable partner in strengthening end to end vaccine development, from early-stage research through to commercial production and market release.

Merck is a global science and technology company delivering high-value products and services across three main sectors: Life Science, Healthcare, and Electronics.

Headquartered in Darmstadt, the company serves customers worldwide with innovative solutions for pharmaceutical development, laboratory research, and advanced materials for electronics applications. Merck operates in more than 60 countries, collaborating with customers to advance science, improve health outcomes, and enable next-generation technologies. The company emphasizes sustainable growth, ethical governance, and long-term partnerships with academia and industry.

Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2025 the company generated sales revenue of around 3.5 billion euros. More than 14,000 employees serve customers around the glob

Corning has been applying unparalleled expertise in glass and ceramic science and optical physics along with deep manufacturing and engineering capabilities to make vital contributions to the world since 1851. The Life Sciences business supports the end-end biopharma workstream. Our business segment operates in 4 areas – research, bioproduction, diagnostics, and drug storage and delivery. From there, we are organized into two divisions, Corning Life Sciences, which is the largest portion of our business, and Corning Pharmaceutical Technologies, which is our fastest growing . We are investing in new plants and capacity for both divisions and expect these investments to help accelerate our growth and better support our global customers.

V&W Biotech Pvt. Ltd., India delivers advanced single-use technologies and end-to-end bioprocess solutions for global biopharmaceutical, bioprocess, and cell & gene therapy industries. Its portfolio spans upstream, downstream, and fill-finish applications, offering single-use systems, assemblies, filtration, and process hardware. Designed for reliability, scalability, and sterility, these solutions support seamless manufacturing integration. The company ensures consistent performance, validation support, and compliance for regulated environments. With a Just-in-Time approach, it reduces lead times and inventory burden while maintaining supply continuity. By combining localized manufacturing with global quality standards, V&W enhances supply chain resilience and enables cost-effective, scalable production from development to commercialization.

TM Media, a brand of Titan Biotech Ltd., has been a trusted provider of top-quality microbial products since 1992. With a strong focus on quality, reliability, and sustainability, we have become a renowned name in the field of microbiology globally. Our diverse product portfolio includes Biological Media Bases, 2500+ Dehydrated Culture Media including Harmonized Media, Media Supplements, Antibiotic Discs, and Ready-to-Use Media. We have established ourselves as one of the industry leaders by continuously enhancing Microbial Culture Strategies, Quality Testing Methods, and Environmental Monitoring techniques. With certifications such as ISO, FSSAI, EU, Halal, and GMP, we ensure international quality standards.

VWR, part of Avantor is the distribution channel of Avantor®, a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side by side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.

City Integrated Research Institute (CIRI) a unit of City Imaging and Clinical Labs (CICL) provides customized, high-quality central laboratory and core imaging services to researchers, academicians, clinicians, CROs and sponsors, offering regulatory-compliant end to end solutions for both safety & along with immunogenicity testing. With scientific expertise, efficient project management, advanced technologies, skilled leadership, and regulatory acumen, CIRI seamlessly manages clinical trials ranging from small-scale academic studies to large, complex, regulatory submission trials.

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.

DCVMN International is a global alliance of over 44 manufacturers from 17 LMICs, collectively supplying more than 60% of the vaccines procured globally and reaching over 170 countries, dedicated to protecting people against infectious diseases through equitable access to affordable, high-quality vaccines. DCVMN fosters collaboration, knowledge-sharing, and capacity-building to strengthen global immunisation supply and security. The Network supports its members through workforce training initiatives, technical exchange, advocacy, and partnerships with global health stakeholders. For over 26 years, DCVMN has championed the role of developing-country manufacturers in expanding vaccine availability worldwide, advancing innovation, and contributing to a healthier, more resilient global community.

The Centre for Cellular and Molecular Platforms (C-CAMP), an initiative supported by the Department of Biotechnology, Government of India, has been catalysing cutting-edge research and innovation in life sciences since 2009. It has positioned itself as India’s premier bio-innovation and technology hub, and one of the largest and most vibrant life sciences incubators in the country, bringing together academia, startups, and industry to create societal impact through deep-science research and innovation.

C-CAMP has directly funded, incubated, and mentored over 650 startups over the last decade and is connected with more than 3,000 startups and entrepreneurs across the country in the domains of healthcare, agriculture, and environment.

Website: https://www.ccamp.res.in/